Heavy Pharmaceutical Holdings: Net profit in 2021 is expected to increase by 9.69%-16.47% year-on-year _ Securities Times Network

Securities Times e Company News, Heavy Pharmaceutical Holdings (000950) released a performance forecast on the evening of January 14. It is expected that the net profit attributable to the parent in 2021 will be 970 million yuan to 1.030 billion yuan, a year-on-year increase of 9.69%-16.47%. In 2021, the company’s hospital pure sales business will recover to a certain extent, the grass-roots terminal business will continue to expand, and the marketing network construction will continue to advance; the company’s vigorously developed equipment business has achieved significant growth, and emerging businesses such as import distribution and traditional Chinese medicine health care have made breakthroughs; In the reporting period, the income from changes in fair value was about 130 million yuan, which is a non-recurring income.